Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma

Embolization of variant hepatic arteries in patients undergoing percutaneous hepatic perfusion for unresectable liver metastases from ocular melanoma

PURPOSEIn patients undergoing percutaneous liver perfusion with melphalan (M-PHP), the presence of variant hepatic arteries (HAs) may require catheter repositioning and thus prolong procedure time. Coil-embolization of variant HAs may enable M-PHP with a single catheter position as occlusion of vari...

Full description

Bibliographic Details
Main Authors:	T. Susanna Meijer, Lioe-Fee de Geus-Oei, Christian H. Martini, Fred G. J. Tijl, M. Elske Sitsen, Arian R. van Erkel, Rutger W. van der Meer, Ellen Kapiteijn, Alexander L. Vahrmeijer, Mark C. Burgmans
Format:	Article
Language:	English
Published:	Galenos Publishing House 2019-11-01
Series:	Diagnostic and Interventional Radiology
Online Access:	http://www.dirjournal.org/archives/archive-detail/article-preview/embolization-of-variant-hepatic-arteries-in-patien/54856

Similar Items

Prospective evaluation of percutaneous hepatic perfusion with melphalan as a treatment for unresectable liver metastases from colorectal cancer.
by: T Susanna Meijer, et al.
Published: (2022-01-01)

Combining Hepatic Percutaneous Perfusion with Ipilimumab plus Nivolumab in advanced uveal melanoma (CHOPIN): study protocol for a phase Ib/randomized phase II trial
by: T. M. L. Tong, et al.
Published: (2022-02-01)

Editorial on Special Issue “Quantitative PET and SPECT”
by: Floris H. P. van Velden, et al.
Published: (2022-08-01)

The Value of <sup>18</sup>F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review
by: Okker D. Bijlstra, et al.
Published: (2022-03-01)

Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study
by: B. G. Sibinga Mulder, et al.
Published: (2019-08-01)

Ablation margin quantification after thermal ablation of malignant liver tumors: How to optimize the procedure? A systematic review of the available evidence
by: Pim Hendriks, et al.
Published: (2023-12-01)

Over 12 Years Single Institutional Experience Performing Percutaneous Hepatic Perfusion for Unresectable Liver Metastases
by: Michael J. Carr MD, MS, et al.
Published: (2020-12-01)

Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation
by: van Coevorden Frits, et al.
Published: (2005-11-01)

Nanocarriers as a Tool for the Treatment of Colorectal Cancer
by: Ana Luiza C. de S. L. Oliveira, et al.
Published: (2021-08-01)

Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma
by: Giovanni Bernardo, et al.
Published: (2009-07-01)

Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma.
by: Wei-Lun Tsai, et al.
Published: (2014-01-01)

Adding the temporal domain to PET radiomic features.
by: Wyanne A Noortman, et al.
Published: (2020-01-01)

Modulation of hepatic perfusion did not improve recovery from hepatic outflow obstruction
by: J. Arlt, et al.
Published: (2017-06-01)

Isolated hepatic perfusion for patients with liver metastases
by: Srinevas K. Reddy, et al.
Published: (2014-07-01)

Stereotactic radiotherapy boost after definite chemoradiation for non-responding locally advanced NSCLC based on early response monitoring 18F-FDG-PET/CT
by: Tineke W.H. Meijer, et al.
Published: (2018-07-01)

Reinducing Radioiodine-Sensitivity in Radioiodine-Refractory Thyroid Cancer Using Lenvatinib (RESET): Study Protocol for a Single-Center, Open Label Phase II Trial
by: Maaike Dotinga, et al.
Published: (2022-12-01)

Impact of the COVID‐19 pandemic on the in‐hospital diagnostic pathway of breast and colorectal cancer in the Netherlands: A population‐based study
by: Wouter Wolfkamp, et al.
Published: (2024-01-01)

Dramatic response to albendazole in transplantation candidates with unresectable hepatic alveolar hydatid disease
by: Sönmez Ocak, et al.
Published: (2021-08-01)

Klatskin tumor presenting as unresectable perihilar hepatic mass: A case report
by: Thierry Romeo Yehouenou Tessi, MD, et al.
Published: (2021-09-01)

Liver transplantation for unresectable hepatic metastases from colorectal cancer: literature review
by: Nicolae BACALBASA, et al.
Published: (2019-06-01)

Striatal dopamine synthesis capacity in autism spectrum disorder and its relation with social defeat: an [18F]-FDOPA PET/CT study
by: Rik Schalbroeck, et al.
Published: (2021-01-01)

CASE OF TREATMENT OF UNRESECTABLE HEPATOCELLULAR CARCINOMA OF THE LIVER THROUGH THE HEPATIC ARTERY CHEMOEMBOLIZATION M
by: A. I. Gritsaenko, et al.
Published: (2017-01-01)

Hepatic Arterial Infusion Chemotherapy versus Trans-arterial Chemoembolization in Unresectable Hepatocellular Carcinoma:
by: Ziad Abuhelwa
Published: (2023-05-01)

Cerebral [<sup>18</sup>F]-FDOPA Uptake in Autism Spectrum Disorder and Its Association with Autistic Traits
by: Rik Schalbroeck, et al.
Published: (2021-12-01)

Unresectable Hepatic Metastasis of Uveal Melanoma: Hepatic Chemosaturation with High-Dose Melphalan—Long-Term Overall Survival Negatively Correlates with Tumor Burden
by: R. Brüning, et al.
Published: (2020-01-01)

Regulation of rat hepatic cholesterol metabolism. Effects of lipoprotein composition on acyl coenzyme A:cholesterol acyltransferase in vivo and in the perfused liver and on hepatic cholesterol secretion
by: P E Van Zuiden, et al.
Published: (1987-08-01)

Hepatic control of perfusate homeostasis during normothermic extrocorporeal preservation.
by: St Peter, S, et al.
Published: (2003)

Fulminant Hepatic Failure after Chemosaturation with Percutaneous Hepatic Perfusion and Nivolumab in a Patient with Metastatic Uveal Melanoma
by: Lindsey Teal, et al.
Published: (2021-01-01)

Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis.
by: Anthony J Zacharias, et al.
Published: (2015-01-01)

Seronegative fibrosing cholestatic hepatitis С after liver retransplantation for unresectable neuroendocrine tumor liver metastases
by: S. E. Voskanyan, et al.
Published: (2020-12-01)

Hepatic arterial infusion chemotherapy with or without lenvatinib for unresectable cholangiocarcinoma: a single-center retrospective study
by: Yajing Wang, et al.
Published: (2023-06-01)

Downstaging Therapies for Unresectable Hepatocellular Carcinoma Prior to Hepatic Resection: A Systematic Review and Meta-Analysis
by: Xinyu Chen, et al.
Published: (2021-11-01)

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
by: Fumagalli Ingrid, et al.
Published: (2012-09-01)

Efficacy and safety of lenvatinib plus durvalumab combined with hepatic arterial infusion chemotherapy for unresectable intrahepatic cholangiocarcinoma
by: Rongce Zhao, et al.
Published: (2024-05-01)

Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model
by: Jamieson, R, et al.
Published: (2011)

Hepatic steatosis and normothermic perfusion-preliminary experiments in a porcine model.
by: Jamieson, R, et al.
Published: (2011)

Numerical Investigations of Hepatic Spheroids Metabolic Reactions in a Perfusion Bioreactor
by: Fatemeh Sharifi, et al.
Published: (2019-09-01)

Isolated chemohyperthermal perfusion of the liver with melphalan in the treatment of unresectable liver metastases with uveal melanoma
by: A. D. Kaprin, et al.
Published: (2021-12-01)

Isolated Limb Perfusion for the Treatment of Unresectable In- Transit Metastases of Cutaneous Squamous Cell Carcinoma
by: Joana Barbosa, et al.
Published: (2021-06-01)

18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) - A prospective externally validated study.
by: Sara Carvalho, et al.
Published: (2018-01-01)